Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Trimmed by Mackenzie Financial Corp

Mackenzie Financial Corp lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 248,725 shares of the medical equipment provider’s stock after selling 91,181 shares during the quarter. Mackenzie Financial Corp owned approximately 0.07% of Intuitive Surgical worth $123,186,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Chilton Capital Management LLC grew its stake in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. Parvin Asset Management LLC acquired a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. Global Financial Private Client LLC increased its holdings in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares during the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical in the first quarter worth approximately $26,000. Finally, Hurley Capital LLC acquired a new position in Intuitive Surgical in the fourth quarter worth approximately $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ISRG. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. UBS Group increased their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Finally, Royal Bank Of Canada increased their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 23rd. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $592.05.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 7,610 shares of company stock valued at $3,858,340. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Down 0.4%

ISRG opened at $493.95 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market capitalization of $177.07 billion, a price-to-earnings ratio of 68.89, a P/E/G ratio of 5.20 and a beta of 1.64. The business has a 50 day moving average of $528.51 and a 200-day moving average of $534.63.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the prior year, the business earned $1.78 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.